FR3094638B1 - Produit pour la prévention et le traitement de la cinétose - Google Patents

Produit pour la prévention et le traitement de la cinétose Download PDF

Info

Publication number
FR3094638B1
FR3094638B1 FR1903645A FR1903645A FR3094638B1 FR 3094638 B1 FR3094638 B1 FR 3094638B1 FR 1903645 A FR1903645 A FR 1903645A FR 1903645 A FR1903645 A FR 1903645A FR 3094638 B1 FR3094638 B1 FR 3094638B1
Authority
FR
France
Prior art keywords
prevention
treatment
product
motion sickness
sickness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1903645A
Other languages
English (en)
Other versions
FR3094638A1 (fr
Inventor
Tiphaine Bricout
Marilyn Gentilhomme
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Urgo Recherche Innovation et Developpement
Original Assignee
Urgo Recherche Innovation et Developpement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urgo Recherche Innovation et Developpement filed Critical Urgo Recherche Innovation et Developpement
Priority to FR1903645A priority Critical patent/FR3094638B1/fr
Priority to PCT/IB2020/052801 priority patent/WO2020201920A1/fr
Publication of FR3094638A1 publication Critical patent/FR3094638A1/fr
Application granted granted Critical
Publication of FR3094638B1 publication Critical patent/FR3094638B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention a pour objet un produit comprenant à titre de substances actives, au moins du pissenlit et du gingembre pour la prévention et/ou le traitement de la cinétose
FR1903645A 2019-04-05 2019-04-05 Produit pour la prévention et le traitement de la cinétose Active FR3094638B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1903645A FR3094638B1 (fr) 2019-04-05 2019-04-05 Produit pour la prévention et le traitement de la cinétose
PCT/IB2020/052801 WO2020201920A1 (fr) 2019-04-05 2020-03-25 Produit pour la prévention et le traitement de la cinetose

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1903645 2019-04-05
FR1903645A FR3094638B1 (fr) 2019-04-05 2019-04-05 Produit pour la prévention et le traitement de la cinétose

Publications (2)

Publication Number Publication Date
FR3094638A1 FR3094638A1 (fr) 2020-10-09
FR3094638B1 true FR3094638B1 (fr) 2023-11-24

Family

ID=69743268

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1903645A Active FR3094638B1 (fr) 2019-04-05 2019-04-05 Produit pour la prévention et le traitement de la cinétose

Country Status (2)

Country Link
FR (1) FR3094638B1 (fr)
WO (1) WO2020201920A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013022044A2 (pt) * 2011-02-28 2016-11-29 Technologies Khlôros Inc veículo mastigável para absorção na boca
KR101930277B1 (ko) * 2017-07-14 2018-12-18 코스맥스 주식회사 숙취 예방 및 개선용 조성물

Also Published As

Publication number Publication date
WO2020201920A1 (fr) 2020-10-08
FR3094638A1 (fr) 2020-10-09

Similar Documents

Publication Publication Date Title
MA43335B1 (fr) Compositions d'arni de transthyrétine (ttr) et procédés pour les utiliser pour le traitement ou la prévention de maladies associées à ttr
MD3573983T2 (ro) N-[4-fluoro-5-[[(2S,4S)-2-metil-4-[(5-metil-1,2,4-oxadiazol-3-il)metoxi]-1-piperidil]metil]tiazol-2-il]acetamidă în calitate de inhibitor OGA
MA53937A (fr) Compositions comprenant des souches bactériennes
MA41496B1 (fr) Compositions pharmaceutiques comprenant n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
MA43982A (fr) Anticorps anti-tnf, compositions, méthodes et utilisation pour le traitement ou la prévention du diabète de type 1
MA45811A (fr) Méthodes et compositions de traitement de maladie.
MA49760A (fr) Mavacamten destiné à être utilisé dans le traitement de la cardiomyopathie hypertrophique
MA40768B1 (fr) Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue
EA202190960A1 (ru) Конденсированные пирролины, которые действуют как ингибиторы убиквитин-специфической протеазы 30 (usp30)
MD3880197T2 (ro) Metode de tratament pentru fibroză chistică
EA201800499A1 (ru) Ингибитор тирозинкиназы для лечения амиотрофного латерального склероза, композиция, лекарственное средство, набор
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
MA53973A (fr) Inhibiteurs de la réplication du virus de l'immunodéficience humaine
FR3063645B1 (fr) Acefapc pour le traitement des maladies acetylcholine dependantes
MA54936A (fr) Triamtérène ou nolatrexed destinés à être utilisés dans le traitement de la phénylcétonurie
EA202190398A1 (ru) Конденсированное кольцевое производное, применяемое в качестве ингибитора fgfr4
EA202190057A1 (ru) Солюбилизированные апиразы, способы и применение
FR3094638B1 (fr) Produit pour la prévention et le traitement de la cinétose
EP3639855A4 (fr) Composés ayant une activité inhibitrice de caspase, agent pharmaceutique les contenant pour le traitement ou la prévention des symptômes, troubles ou maladies de l'endothélium cornéen, et application dudit agent pharmaceutique
MA39448B1 (fr) (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical
EA202191469A1 (ru) Восстановление посредством антисмысловых олигонуклеотидов abca4 с аберрантным сплайсингом
FR3070263B1 (fr) Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite
FR3059237B1 (fr) Utilisation d'une composition bacterienne pour traiter des pathologies animales
EA202191124A1 (ru) Лекарственная форма для лечения и профилактики гриппа и орви
MA54630B1 (fr) N,n-bis-2-mercaptoéthyle isophtalamide pour le traitement des maladies neurodégénératives

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20201009

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6